Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.27 - $7.7 $197,630 - $242,704
31,520 New
31,520 $198,000
Q3 2023

Nov 13, 2023

SELL
$8.91 - $10.91 $4.01 Million - $4.91 Million
-450,000 Reduced 56.25%
350,000 $3.2 Million
Q2 2023

Aug 10, 2023

SELL
$7.14 - $9.29 $714,000 - $928,999
-100,000 Reduced 11.11%
800,000 $7.33 Million
Q1 2023

May 09, 2023

BUY
$6.65 - $10.69 $4.32 Million - $6.95 Million
650,000 Added 260.0%
900,000 $6.63 Million
Q4 2022

Feb 10, 2023

BUY
$5.96 - $8.53 $1.49 Million - $2.13 Million
250,000 New
250,000 $2.13 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.